Tower Research Capital LLC (Trc) Atai Life Sciences N.V. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 12,275 shares of ATAI stock, worth $21,235. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,275
Previous 17,225
28.74%
Holding current value
$21,235
Previous $22,000
36.36%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding ATAI
# of Institutions
87Shares Held
12.4MCall Options Held
77.8KPut Options Held
50.3K-
Morgan Stanley New York, NY3.04MShares$5.26 Million0.0% of portfolio
-
Walleye Capital LLC Plymouth, MN2.26MShares$3.92 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.31MShares$2.26 Million0.0% of portfolio
-
Brown University719KShares$1.24 Million0.36% of portfolio
-
Round Table Services, LLC704KShares$1.22 Million0.46% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $287M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...